about
Guidelines for the use and interpretation of assays for monitoring autophagyCritical illness-induced bone loss is related to deficient autophagy and histone hypomethylation.Indication and practical use of intensive insulin therapy in the critically ill.Impact of early parenteral nutrition on metabolism and kidney injuryGlycaemic control and perioperative organ protection.Blood glucose control in the intensive care unit: benefits and risks.AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin.Parenteral nutrition in the critically ill.Continuous glucose monitoring in the ICU: clinical considerations and consensus.Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial.FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.Recovery from AKI in the critically ill: potential confounders in the evaluation.Blood glucose control in the ICU: how tight?Recovery from critical illness-induced organ failure: the role of autophagy.Acute severe illness in diabetes patients: is tolerating hyperglycemia beneficial?A liberal glycemic target in critically ill patients with poorly controlled diabetes?Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients.Alterations in adipose tissue during critical illness: An adaptive and protective response?Enhanced immunoreceptor tyrosine-based activation motif signaling is related to pathological bone resorption during critical illness.Impact of hyperglycemia on neuropathological alterations during critical illness.Hyperglycemic kidney damage in an animal model of prolonged critical illness.[Glycemic control in the intensive care unit].Anterior pituitary morphology and hormone production during sustained critical illness in a rabbit model.Amino acid supplements in critically ill patients.Endocrine and Metabolic Alterations in Sepsis and Implications for Treatment.Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness.Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients.Early parenteral nutrition evokes a phenotype of autophagy deficiency in liver and skeletal muscle of critically ill rabbits.Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial.The impact of using estimated GFR versus creatinine clearance on the evaluation of recovery from acute kidney injury in the ICU.The optimal blood glucose target in critically ill patients: more questions than answers.Critical Care Management of Stress-Induced HyperglycemiaGlucose, Insulin, and the KidneyCritical illness — another trial, but are we any wiser?Blood glucose control in the ICU: don’t throw out the baby with the bathwater!Is protein intake saturated at doses recommended by the feeding guidelines for critically ill patients?Intensive Care Nutrition and Post–Intensive Care RecoveryAutophagy and Its Implications Against Early Full Nutrition Support in Critical IllnessImproving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreasRole of glucagon in protein catabolism
P50
Q21996341-9DA7448F-F3BD-492B-BC8C-2D2F5AD61D60Q35780085-3C1D9DCD-59EA-4C57-82BA-7D114783D2C4Q36863943-FF2A993D-5CDC-439E-9EF6-9FAE18355874Q36880413-854C5591-C963-4BB5-9995-6D71D6B45E60Q37169536-9FE0EBE8-C0F4-4856-83A4-4FC38D797D4EQ37762854-2C30CD78-69DD-461C-9694-E5A0E015E082Q38994344-6ACF40D1-CF83-4003-ADBA-D0DC04B323A0Q39082981-084A1EE6-56B1-4CD5-9058-132488A57C4DQ39148479-FE74A304-50ED-44F7-B58C-939B9A0D7AADQ40206885-53240DA3-7E11-445C-AF05-07DAE1CE5DD7Q41482545-200221D9-8F93-4E20-81CF-C68C15B797B3Q41602208-19BD56D6-E9D4-44AB-9A62-05CE86C5D03BQ42318345-7AF6CC31-A5F3-47FC-AE35-8502B753510BQ42343351-3AE832E7-87E3-46CC-9B22-50A39EA78270Q42344270-F4FA0186-73A6-46B9-8955-4CC836D51D70Q42370329-E7B4B0BD-44F5-4E35-94D9-93F223BFB9C7Q42687663-AE8173D7-B643-497A-91D0-E16507907062Q43074167-B2BF46E8-1C0A-4AF0-9FF0-DD0A7A4E61FFQ43634837-2F544F2F-59F8-4A40-AEF8-5895816D9D95Q44633683-EB2B84D0-25C9-4953-9FA2-18196C8DFE6EQ45964649-8373898A-4B97-4111-B5C9-D455E54ACE72Q46027930-BCCFE096-7D36-4439-8C69-9F28DC8CA3C8Q46036247-8B189DB6-CA98-4CF0-A4CB-BD49E1D5ABBCQ47312050-970C75BD-8653-4FD8-B448-4F8907CBB195Q49917329-3D43699D-444B-4A42-BBDA-0843978D7EC7Q50890213-9F860CCE-31DF-4601-9AEF-0BC144674820Q50999367-E0B6371E-06B4-4A58-9E88-082993DA4C88Q51360039-863EF866-6565-4448-8D20-4A494757A935Q53070565-73B174FA-AA4A-4249-9EA4-C86B231A2CEEQ53155261-EF1538E2-4532-4CF7-BE78-4C565F1F6C6DQ53750781-424D7166-A97C-4505-8268-A56A608A4C69Q57245080-BBCC906B-5ECA-4E7F-AEFC-CD67F9D9EB27Q57245104-1E118B47-CCFD-494C-AC81-D75F805EC2FEQ57245161-EFED365B-E062-4286-982C-6308D612F17AQ57245173-D6184DBA-FC56-4822-9E97-C55D2473646DQ57663755-97AB23E5-F702-402B-9AC5-F85EAC268D45Q57663758-D484AD83-06F4-4749-BCA5-ACAC0EB77474Q57663762-4738D42F-FBDF-4ABF-9A34-ECD9F104667DQ57663772-881AA547-C76C-4DE1-8251-F27835E36A1EQ57663776-7499B2E8-6E1A-4ED0-80E5-1E7D323DAD1E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Gunst
@ast
Jan Gunst
@en
Jan Gunst
@es
Jan Gunst
@nl
type
label
Jan Gunst
@ast
Jan Gunst
@en
Jan Gunst
@es
Jan Gunst
@nl
prefLabel
Jan Gunst
@ast
Jan Gunst
@en
Jan Gunst
@es
Jan Gunst
@nl
P1053
L-9099-2018
P106
P1153
36723320500
P31
P496
0000-0003-2470-6393